(2001). Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev
(1992). Developing bronchopulmonary epithelium of the human fetus secretes fluid.
Development of human fetal lung in organ culture compared with in utero ontogeny.
Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med JT - Free radical biology &
(1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
(1996). Differential release of prostaglandins by organ cultures of human fetal trachea and lung.
Differentiation of type II cells of human fetal lung in vitro.
Differentiation-arrested rat fetal lung in primary monolayer cell culture. IV. Paradoxical effect of a "fetal" pO2 on precursor incorporation into phospholipids and hormone responsiveness.
(2000). Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev
(2000). Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev
(1995). Effect of IL-1 blockade on inflammatory manifestations of acute ventilator-induced lung injury in a rabbit model. Exp Lung Res
Effect of serum and cell density on transmembrane distribution of cAMP and cGMP in transformed (C4-I) and non-transformed (WI-38) human cells.
Effect of type I collagen on the adhesion, proliferation, and osteoblastic gene expression of bone marrowderived mesenchymal stem cells.
Effects of adrenaline and of spontaneous labour on the secretion and absorption of lung liquid in the fetal lamb.
(1997). Effects of antenatal and postnatal corticosteroids on the preterm lung. Arch Dis Child Fetal Neonatal Ed
(2000). Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia. Pediatr Pulmonol
(2003). Effects of hyperoxia on VEGF, its receptors and HIF2alpha in the newborn rat lung.
(1980). Effects of inspired oxygen on echocardiographic assessment of pulmonary vascular resistance and myocardial contractility in bronchopulmonary dysplasia. Pediatrics JT - Pediatrics.
(1998). Effects of mesenchyme on epithelial tissue architecture revealed by tissue recombination experiments between the submandibular gland and lung of embryonic mice.
(1996). Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.
(1996). Eliminating sleep-associated hypoxemia improves growth in infants with bronchopulmonary dysplasia. Pediatrics JT - Pediatrics.
(1996). Epidermal growth factor, but not hepatocyte growth factor, suppresses the apoptosis induced by transforming growth factor-beta in fetal hepatocytes in primary culture.
Epithelial cell differentiation in organotypic cultures of fetal rat lung.
(1997). Epithelial morphogenesis in mouse embryonic submandibular gland: its relationships to the tissue organization of epithelium and mesenchyme. Dev Growth Differ
Epithelial-mesenchymal interaction during lung development: the effect of mesenchymal mass.
(2003). Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev JT - Cochrane database of systematic reviews (Online)
(1997). Execution mechanisms of programmed cell death by caspase (ICE/CED-3) family proteases. Heart Vessels
Experimental models of bronchopulmonary dysplasia.
(1998). Expression and developmental profile of antioxidant enzymes in human lung and liver.
(1993). Failure of cromolyn sodium to reduce the incidence of bronchopulmonary dysplasia: a pilot study. The Neonatal Cromolyn Study Group. Pediatrics
(1991). Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatr Res
(1991). Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight.